2020 Virtual Fall Conference: Psychopharmacology and Telepsychiatry Updates

Please join us as we bring our popular psychopharmacology conference to you virtually this fall. We have five engaging speakers bringing timely and relevant topics in an engaging virtual format. 

We plan to make this an engaging CME event that will be well worth your time, with an amazing line-up of speakers and topics. This conference will cover the following learning objectives:

• To have a better understanding and knowledge of updates on psychopharmalogical interventions for a variety of psychiatric disorders
• To be able to compare and list the pharmacologic approaches to treatment
• To develop knowledge and be able to recognize psychopharmacological emergencies and how best diagnose and manage them 
• To increase knowledge about the history, severity and new treatment options for bipolar disorder
• To increase knowledge about women's mental health and prescribing various psychotropic medications with non-pharmacologic options for pregnant or menopausal patients
• To increase knowledge about telehealth and the impacts on mental healthcare delivery and how to build alliances and overcome telehealth barriers

Date: Satruday, October 3, 2020

Time: 9:30 a.m. - 3:45 p.m.

Rates: 
Resident/Fellow Member : Free
Early Career Member (1st 8 years of practice): $15
General Member: $30
Non-member: $60

Please mark your calendars and register today!

Accreditation 
This activity has been planned and implemented in accordance with the accreditation requirements and
policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Psychiatric Association (APA) and Northern California Psychiatric Society. The APA is accredited by the ACCME to provide continuing medical education for physicians. 

Designation 
The APA designates this live activity for a maximum of 5 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.